CN1490017A - Medicines against rheunatoid and rheumatic diseases - Google Patents
Medicines against rheunatoid and rheumatic diseases Download PDFInfo
- Publication number
- CN1490017A CN1490017A CNA021314403A CN02131440A CN1490017A CN 1490017 A CN1490017 A CN 1490017A CN A021314403 A CNA021314403 A CN A021314403A CN 02131440 A CN02131440 A CN 02131440A CN 1490017 A CN1490017 A CN 1490017A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- herba
- chinese medicine
- aconiti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating rheumatic and rheumatoid diseases, hyperosteogeny and palsy caused by cerebral hemorrhage is prepared from 32 Chinese-medicinal materials including Chuan-xiong rhizome, Chinese angelica root, astragalus root, white peony root, etc.
Description
Invention field
The present invention relates to a kind of medicine for the treatment of rheumatoid, rheumatism.
Background technology
Rheumatism, rheumatoid disease are common clinicals, are symptom with arthralgia, swelling mainly, cause very big misery to the patient, rheumatoid especially, and severe patient can cause life and work to be subjected to obstacle, even disabled.Since etiology unknown, clinical no specific therapy method.Rheumatism is mainly treated with anti-inflammatory agent.Rheumatoid disease is mainly used treatments such as anti-inflammatory agent, 17-hydroxy-11-dehydrocorticosterone, immunosuppressant.These medicines can alleviating pain, but does not have obvious effect for PD, and exists multiple side effect.Therefore, wish that exploitation can effectively improve the state of an illness of rheumatism, rheumatoid disease, and the medicine of non-evident effect.
Summary of the invention
The inventor is engaged in clinical position for many years, on the basis of summing up clinical practice, through repetition test, screening of medicaments, developing the medicine of a kind of effective treatment rheumatoid, rheumatism, facial paralysis, hyperosteogeny, cerebral hemorrhage paralysis sequela, is Chinese medicine composition specifically.
Medicine of the present invention comprises:
Radix Angelicae Pubescentis 5-25 Herba Taxilli 6-20 Radix Gentianae Macrophyllae 5-20 Radix Saposhnikoviae 5-20
Rhizoma Chuanxiong 5-15 Radix Angelicae Sinensis 5-20 Ramulus Cinnamomi 1-15 Radix Achyranthis Bidentatae 5-20
Radix Codonopsis 5-20 Radix Astragali 10-60 Fructus Corni 5-40 Semen Cuscutae 5-40
Herba speranskiae tuberculatae 20-80 Rhizoma Dioscoreae Nipponicae 10-40 Rhizoma Homalomenae 10-30 Rhizoma Corydalis 10-40
Semen Arecae 5-25 Fructus Crataegi 10-60 Radix Clematidis 8-30 Herba Bidentis Bipinnatae 6-40
Radix Aconiti 5-16 Radix Aconiti Kusnezoffii 5-16 Radix Parthenocissi Heterophyllae 10-30 Rhizoma Atractylodis Macrocephalae 8-20
Radix Paeoniae Alba 10-35 Radix Paeoniae Rubra 10-25 Flos Carthami 6-20 Zaocys 10-30
Herba Lycopodii 5-20 Lycopodium casuarinoides Spring 8-25 Caulis Spatholobi 8-30 Radix Puerariae 10-40
Wherein calculate by weight in all cases.
Preferred group of the present invention becomes:
Radix Angelicae Pubescentis 10-20 Herba Taxilli 10-15 Radix Gentianae Macrophyllae 10-15 Radix Saposhnikoviae 10-15
Rhizoma Chuanxiong 10-12 Radix Angelicae Sinensis 10-15 Ramulus Cinnamomi 1-12 Radix Achyranthis Bidentatae 10-15
Radix Codonopsis 10-15 Radix Astragali 20-30 Fructus Corni 10-30 Semen Cuscutae 10-30
Herba speranskiae tuberculatae 30-60 Rhizoma Dioscoreae Nipponicae 20-30 Rhizoma Homalomenae 15-20 Rhizoma Corydalis 20-30
Semen Arecae 10-20 Fructus Crataegi 20-60 Radix Clematidis 12-20 Herba Bidentis Bipinnatae 20-30
Radix Aconiti 10-15 Radix Aconiti Kusnezoffii 10-15 Radix Parthenocissi Heterophyllae 15-20 Rhizoma Atractylodis Macrocephalae 12-15
Radix Paeoniae Alba 20-30 Radix Paeoniae Rubra 15-20 Flos Carthami 8-15 Zaocys 15-20
Herba Lycopodii 10-15 Lycopodium casuarinoides Spring 10-18 Caulis Spatholobi 10-20 Radix Puerariae 20-30
Wherein calculate by weight in all cases.
Medicine of the present invention has expelling wind and removing dampness, relaxes through the function of collateral dredging, promoting blood circulation and stopping pain, replenishing QI to invigorate the spleen, has tangible curative effect for rheumatism, rheumatoid, facial paralysis, hyperosteogeny, cerebral hemorrhage paralysis sequela etc., can alleviate or eliminate clinical symptoms such as pain, swelling etc., stop or the inhibition PD, improve clinical prognosis, thereby reach the purpose of thorough treatment.
Can above-mentioned composition of the present invention be made various pharmaceutical preparatioies by the common method of this area, for example pill, oral liquid, powder, capsule etc.
For example, can concentrate, make concentrated capsule by the said medicine water is fried.
Drug dose of the present invention is normally in 10-100g (all gross weight meters of raw material)/day, in the scope of preferred 20-50g/ day.
The suitable administering mode of medicine of the present invention is oral.
Embodiment
Below in conjunction with embodiment the present invention is described, it should be understood that given embodiment only is used for illustrative purposes, is not construed as limiting the invention.
Embodiment 1
Radix Angelicae Pubescentis 12g Herba Taxilli 10g Radix Gentianae Macrophyllae 14g Radix Saposhnikoviae 12g
Rhizoma Chuanxiong 11g Radix Angelicae Sinensis 10g Ramulus Cinnamomi 10g Radix Achyranthis Bidentatae 10g
Radix Codonopsis 15g Radix Astragali 20g Fructus Corni 15g Semen Cuscutae 15g
Herba speranskiae tuberculatae 60g Rhizoma Dioscoreae Nipponicae 15g Rhizoma Homalomenae 15g Rhizoma Corydalis 25g
Semen Arecae 10g Fructus Crataegi 30g Radix Clematidis 14g Herba Bidentis Bipinnatae 20g
Radix Aconiti 15g Radix Aconiti Kusnezoffii 15g Radix Parthenocissi Heterophyllae 15g Rhizoma Atractylodis Macrocephalae 13g
Radix Paeoniae Alba 20g Radix Paeoniae Rubra 15g Flos Carthami 9g Zaocys 15g
Herba Lycopodii 10g Lycopodium casuarinoides Spring 12g Caulis Spatholobi 10g Radix Puerariae 20g
Above-mentioned raw materials is decocted with water, and the simmer down to paste incapsulates, every 0.5g, the 4-5 grain/time, every day 3 times, 1 month was 1 course of treatment, 1-2 course of treatment of rheumatism general treatment, rheumatoid need be kept treatment 1-3 usually, and cerebral hemorrhage paralysis sequela generally need be treated 3 months to 1 year.
Embodiment 2
Radix Angelicae Pubescentis 20g Herba Taxilli 15g Radix Gentianae Macrophyllae 10g Radix Saposhnikoviae 10g
Rhizoma Chuanxiong 12g Radix Angelicae Sinensis 15g Ramulus Cinnamomi 5g Radix Achyranthis Bidentatae 15g
Radix Codonopsis 10g Radix Astragali 30g Fructus Corni 10g Semen Cuscutae 10g
Herba speranskiae tuberculatae 40g Rhizoma Dioscoreae Nipponicae 20g Rhizoma Homalomenae 15g Rhizoma Corydalis 20g
Semen Arecae 10g Fructus Crataegi 30g Radix Clematidis 12g Herba Bidentis Bipinnatae 30g
Radix Aconiti 15g Radix Aconiti Kusnezoffii 15g Radix Parthenocissi Heterophyllae 15g Rhizoma Atractylodis Macrocephalae 13g
Radix Paeoniae Alba 20g Radix Paeoniae Rubra 15g Flos Carthami 9g Zaocys 20g
Herba Lycopodii 15g Lycopodium casuarinoides Spring 15g Caulis Spatholobi 10g Radix Puerariae 20g
Above-mentioned raw materials is decocted with water, and the simmer down to paste incapsulates, every 0.5g, the 4-5 grain/time, every day 3 times, 1 month was 1 course of treatment, 1-2 course of treatment of rheumatism general treatment, rheumatoid need be kept treatment 1-3 usually, and cerebral hemorrhage paralysis sequela generally need be treated 3 months to 1 year.
Through clinical statistics, medicine of the present invention is treated rheumatism, rheumatoid, hyperosteogeny, cerebral hemorrhage paralysis sequela totally 600 many cases altogether at 91-93, age 14-81 year, total obvious effective rate reaches more than 98%, especially rheumatoid patient major part after treating can reach long-term remission, and clinical observation is without any side effects.
Claims (3)
1, a kind of Chinese medicine composition that can be used for treating rheumatoid, rheumatism, hyperosteogeny, cerebral hemorrhage paralysis sequela, it comprises:
Radix Angelicae Pubescentis 5-25 Herba Taxilli 6-20 Radix Gentianae Macrophyllae 5-20 Radix Saposhnikoviae 5-20
Rhizoma Chuanxiong 5-15 Radix Angelicae Sinensis 5-20 Ramulus Cinnamomi 1-15 Radix Achyranthis Bidentatae 5-20
Radix Codonopsis 5-20 Radix Astragali 10-60 Fructus Corni 5-40 Semen Cuscutae 5-40
Herba speranskiae tuberculatae 20-80 Rhizoma Dioscoreae Nipponicae 10-40 Rhizoma Homalomenae 10-30 Rhizoma Corydalis 10-40
Semen Arecae 5-25 Fructus Crataegi 10-60 Radix Clematidis 8-30 Herba Bidentis Bipinnatae 6-40
Radix Aconiti 5-16 Radix Aconiti Kusnezoffii 5-16 Radix Parthenocissi Heterophyllae 10-30 Rhizoma Atractylodis Macrocephalae 8-20
Radix Paeoniae Alba 10-35 Radix Paeoniae Rubra 10-25 Flos Carthami 6-20 Zaocys 10-30
Herba Lycopodii 5-20 Lycopodium casuarinoides Spring 8-25 Caulis Spatholobi 8-30 Radix Puerariae 10-40
Wherein calculate by weight in all cases.
2, according to the Chinese medicine composition of claim 1, comprising:
Radix Angelicae Pubescentis 10-20 Herba Taxilli 10-15 Radix Gentianae Macrophyllae 10-15 Radix Saposhnikoviae 10-15
Rhizoma Chuanxiong 10-12 Radix Angelicae Sinensis 10-15 Ramulus Cinnamomi 1-12 Radix Achyranthis Bidentatae 10-15
Radix Codonopsis 10-15 Radix Astragali 20-30 Fructus Corni 10-30 Semen Cuscutae 10-30
Herba speranskiae tuberculatae 30-60 Rhizoma Dioscoreae Nipponicae 20-30 Rhizoma Homalomenae 15-20 Rhizoma Corydalis 20-30
Semen Arecae 10-20 Fructus Crataegi 20-60 Radix Clematidis 12-20 Herba Bidentis Bipinnatae 20-30
Radix Aconiti 10-15 Radix Aconiti Kusnezoffii 10-15 Radix Parthenocissi Heterophyllae 15-20 Rhizoma Atractylodis Macrocephalae 12-15
Radix Paeoniae Alba 20-30 Radix Paeoniae Rubra 15-20 Flos Carthami 8-15 Zaocys 15-20
Herba Lycopodii 10-15 Lycopodium casuarinoides Spring 10-18 Caulis Spatholobi 10-20 Radix Puerariae 20-30
Wherein calculate by weight in all cases.
3, the preparation method of claim 1 or 2 medicine comprises described raw material of Chinese medicine water friedly, makes concentrated capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02131440 CN1203879C (en) | 2002-10-14 | 2002-10-14 | Medicines against rheunatoid and rheumatic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02131440 CN1203879C (en) | 2002-10-14 | 2002-10-14 | Medicines against rheunatoid and rheumatic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1490017A true CN1490017A (en) | 2004-04-21 |
| CN1203879C CN1203879C (en) | 2005-06-01 |
Family
ID=34144936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02131440 Expired - Fee Related CN1203879C (en) | 2002-10-14 | 2002-10-14 | Medicines against rheunatoid and rheumatic diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1203879C (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293906C (en) * | 2004-09-17 | 2007-01-10 | 修涞贵 | Chinese medicine preparation for treating rheumatism stagnation-syndrome pain |
| CN1326535C (en) * | 2005-11-24 | 2007-07-18 | 安徽九鼎医药科技有限公司 | Medicine for treating bong arthritis and its preparing method |
| CN100455280C (en) * | 2006-05-01 | 2009-01-28 | 杨树民 | An externally applied ointment |
| CN102716166A (en) * | 2012-07-10 | 2012-10-10 | 无锡市第三人民医院 | Method for extracting total flavonoids of bidens bipinnata and application of total flavonoids of bidens bipinnata (TFB) in preparation of medicine for treating rheumatoid arthritis |
| CN102872293A (en) * | 2011-07-11 | 2013-01-16 | 侯贤明 | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease |
| CN103211932A (en) * | 2013-03-18 | 2013-07-24 | 赵霞 | Traditional Chinese medicine composition for treating rheumatism |
| CN103720851A (en) * | 2013-12-19 | 2014-04-16 | 王星月 | Traditional Chinese medicinal decoction for treating osteoproliferation |
| CN103893490A (en) * | 2014-04-22 | 2014-07-02 | 李兆洪 | Traditional Chinese medicine formula for treating rheumatoid joint diseases |
| CN104623593A (en) * | 2015-01-08 | 2015-05-20 | 季一艮 | Externally-used medicinal composition for treating cold arthritis |
| CN104893914A (en) * | 2015-05-13 | 2015-09-09 | 河南省新境界酒业有限公司 | Health wine with tendons relaxing and collaterals activating functions |
-
2002
- 2002-10-14 CN CN 02131440 patent/CN1203879C/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293906C (en) * | 2004-09-17 | 2007-01-10 | 修涞贵 | Chinese medicine preparation for treating rheumatism stagnation-syndrome pain |
| CN1326535C (en) * | 2005-11-24 | 2007-07-18 | 安徽九鼎医药科技有限公司 | Medicine for treating bong arthritis and its preparing method |
| CN100455280C (en) * | 2006-05-01 | 2009-01-28 | 杨树民 | An externally applied ointment |
| CN102872293A (en) * | 2011-07-11 | 2013-01-16 | 侯贤明 | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease |
| CN102716166A (en) * | 2012-07-10 | 2012-10-10 | 无锡市第三人民医院 | Method for extracting total flavonoids of bidens bipinnata and application of total flavonoids of bidens bipinnata (TFB) in preparation of medicine for treating rheumatoid arthritis |
| CN103211932A (en) * | 2013-03-18 | 2013-07-24 | 赵霞 | Traditional Chinese medicine composition for treating rheumatism |
| CN103211932B (en) * | 2013-03-18 | 2015-06-10 | 李新 | Traditional Chinese medicine composition for treating rheumatism |
| CN103720851A (en) * | 2013-12-19 | 2014-04-16 | 王星月 | Traditional Chinese medicinal decoction for treating osteoproliferation |
| CN103720851B (en) * | 2013-12-19 | 2015-09-02 | 方继锋 | A kind of Chinese medicine decoction for the treatment of hyperosteogeny |
| CN103893490A (en) * | 2014-04-22 | 2014-07-02 | 李兆洪 | Traditional Chinese medicine formula for treating rheumatoid joint diseases |
| CN104623593A (en) * | 2015-01-08 | 2015-05-20 | 季一艮 | Externally-used medicinal composition for treating cold arthritis |
| CN104893914A (en) * | 2015-05-13 | 2015-09-09 | 河南省新境界酒业有限公司 | Health wine with tendons relaxing and collaterals activating functions |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1203879C (en) | 2005-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100342889C (en) | Chinese medicine for treating gout | |
| CN1193775C (en) | Rheumatoid disease treating capsule | |
| CN1203879C (en) | Medicines against rheunatoid and rheumatic diseases | |
| CN1166388C (en) | Medicine for treating nosal inflammation | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN108514627B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
| CN1186042C (en) | Chinese medicine composition for curing AIDS and its preparation mehtod | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN1814153A (en) | Medicine composition for preventing and treating breast cancer and preparing method | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1799614A (en) | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof | |
| CN101637536B (en) | Medicine for treating chronic sinusitis and preparation method thereof | |
| CN100579569C (en) | Oral Chinese medicine composition for treating liver cirrhosis | |
| CN1470271A (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1244370C (en) | Medicinal composition for curing skin disease | |
| CN1586512A (en) | Medicine for treating liver disease | |
| CN1814250A (en) | Chinese medicine composition for treating liver cirrhosis ascites and use thereof | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
| CN1161135C (en) | Medicine for curing carcinoma of stomach | |
| CN1709478A (en) | Method for preparing Chinese medicine formulation for treating gynaecological disease | |
| CN1438015A (en) | Medicine for treating colontis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |